Case Conference 1/6/16
|
|
- Melanie Bennett
- 8 years ago
- Views:
Transcription
1 Case Conference 1/6/16
2 27 year old woman CC: bruising PMH: Healthy Meds: Multivitamin 4,000 IU vitamin D Fish oil Probiotic Allergies: none Family Hx: Maternal GF - Lung Ca & vasculitis Paternal GF - Heart disease Paternal GM - melanoma Maternal Uncle - melanoma Social Hx: Single Smoker - 5 yr pack hx Occasional ETOH Occasional marijuana use Server at Champs
3 HPI ROS Completed a detox diet ~ one month ago (no gluten, sugar, ETOH, or dairy for 2 weeks) 2 days later, she developed excessive bruising with large generalized areas of discoloration Bruising for the past month Also noted new menorrhagia, nose bleeds, & hematochezia + Fatigue and night sweats. No weight loss Hematochezia: streaks of blood on tissue, painless Menorrhagia: for the past 2 cycles, changes pads/ tampons q45 min Bleeding/Bruising: unprovoked, gums bleed with flossing Questions?
4 Exam Vitals: 98.7F BP 122/78 HR 104 RR 16 BMI 32.4 Gen: NAD, anxious HEENT: normal Resp: CTAB CV: tachycardic, regular, no murmur Abd: Non-tender Lymph: no palpable cervical or axillary adenopathy Skin: Bruising on truck, abdomen, arms, wrists, legs, and ankles + petechiae on face
5 What do you want next? INR: 1.4 CBC report also commented that there was a scatter pattern suspicious for immature WBCs Trauma Infxn Neopl Cong Heme Endo Met Psych Vasc Inflam
6 ANW Admission PCP contacted Dr. Bloom the following day & hospitalization was recommended Additional history on admit: + nausea, poor appetite, loose stools, no herbal medications Exam was unchanged Labs were repeated: MCV 106 Additional Labs: Albumin: 4.2 Tot/Direct Bili: 0.6 / 0.2 ALT & AST: 17 & 20 INR: 1.3 PTT: 25 Fibrinogen: 115 D Dimer >4
7 What would you like to order next? 1. Peripheral Smear 2. CT Chest/Abd/Pelvis 3. Haptoglobin 4. Iron Studies 5. BMP 6. Differential Several Concerns: - She had blasts: - Figure out what else is going on in the blood / marrow: get a diff and check a smear - She was Bleeding, her Fibrinogen & platelets were low, & INR was high - Think DIC, DIC, DIC 7. Other
8 Uric Acid: 6.1 LD: 531 Few elliptocytes, few tear drop cells, circulating blasts with auer rods What are you thinking now?
9 Oncology Consult Assessment: Circulating blasts + Auer rods highly suggestive of APL Clinical picture also consistent with DIC (due to leukemia) Plan: BM biopsy + cytogenetic testing - t(15;17) Begin ATRA (given high suspicion for APL) Follow for bleeding; transfuse cryo to keep fibrinogen >100 and platelets for counts <30. Start allopurinol to prevent tumor lysis
10 Hospital Day 2 BM confirmed APL with t(15;17) Felt to have good-intermediate risk disease (WBC 10,000) Plan Start induction chemo with ATRA + ATO (Arsenic Trioxide) & premeditate with dexamethasone Continue to follow counts and transfuse prn Observe for risk of differentiation syndrome & Torsades Differentiation Syndrome (retinoic acid syndrome) Potentially fatal complication of induction chemo in patients with APL Fever, edema, pulmonary opacities, hypoxemia, respiratory distress, hypotension, renal/hepatic dysfunction, rash, serositis (pleural & pericardial effusions) All due to cytokine storm - release of inflammatory cytokines from malignant promyelocytes Occurs in ~25% treated with ATRA or ATO
11 Hospital Course Responded to treatment well Only a few more episodes of bruising and gingival bleeding She required several platelet transfusions to keep platelets >30 WBC trended up (significantly) - by HD 10 her WBC had risen to 80,000 and she developed HA and left arm weakness. STAT MRI was negative for stroke. Hydroxyurea was started to try to decrease counts WBC rose to 91,000 by HD 11 and ATRA/ATO was held due to concern for differentiation syndrome WBC began trending down and treatment was restarted by HD 16 By HD 32 she was finally transfusion Independent and was able to discharge home She returned for ongoing ATO infusions and eventually started consolidation therapy She also developed significant pain all over and required dilaudid PCA - pain was attributed to marrow expansion
12 Acute Leukemias
13 AML Group of hematopoietic neoplasms involving precursor cells committed to the myeloid line of cellular development These precursor cells proliferate, but have reduced capacity to differentiate into more mature cellular elements This leads to: Accumulation of immature forms/blasts in BM, peripheral blood & other tissues Decreased RBC, platelets, & neutrophils Anemia, Bleeding, & Infection
14 Epidemiology Most common type of acute leukemia in adults Average age of 65 Men > Women Incidence increases with age: 1.3/100,000 in those < /100,000 in those >65 Incidence is similar between races
15 Risk Factors
16 What is true about the presentation of AML? 1. Fevers are usually due to an underlying infection Fever is almost always due to an infection 2. Lymphadenopathy is a common finding on exam Palpable lymphadenopathy is rare 3. Hepatosplenomegaly is common finding on exam Organomegaly is present in only 10% of cases (& often from evolution of MPD into AML) 4. 1&2 are true
17 Signs & Symptoms Related to complications of BM failure / pancytopenia Weakness/fatigue Infections Hemorrhagic findings (gingival bleeding, ecchymoses, epistaxis, menorrhagia) Bone pain infrequent When present, due to expansion of medullary cavity by leukemic process Oropharyngeal Signs Gingival Hypertrophy Oral candidiasis Herpetic lesions
18 Extramedullary Disease Myeloid Sarcoma: solid tumor composed of Immature WBCs that occurs outside the BM (virtually any organ or tissue) <1% will have prominent extramedullary disease Most common presentations (usually with BM involvement) Cutaneous Infiltration leukemia cutis (violaceous non-tender cutaneous plaques) Sweet syndrome (acute neutrophilic dermatosis) Gingival infiltration
19 Complications and their treatments Commonly due to high cellular turnover & bone marrow infiltration Anemia, infection, & Bleeding 1. Thrombocytopenia 2. Abnormal Platelet Function 3. DIC Common in Malignancy Common in APL Leukostasis (mainly CNS & Resp Sx) Leukapheresis or Hydroxyurea Tumor Lysis Syndrome (High Phos, Uric Acid, and K & low Ca) Fluids & Allopurinol +/- Rasburicase High # of WBCs can also interfere with certain labs (spuriously high K or low glucose) Transfusions prn for anemia & DIC ATRA for DIC from APL Increased WBC (>50,000) > leads to WBC plugs in microvasculature % of new AML cases - Diagnosed Empirically - Untreated Mortality is 20-40%
20 Diagnosis Presumptive: circulating blasts May not have leukocytosis Definitive: BM aspirate & biopsy Marrow infiltration (20% of the cells from aspirate must be blasts) Need to have both to make the diagnosis Leukemic cells must be of myeloid origin OR - peripheral blood can have 20% blasts
21 Peripheral smear 75% will have platelets <100 25% will be <25 Median leukocyte count % will be < 5 > 95% will have circulating blasts detectable on smears +/- Auer rods Depends on AML Subtype
22 Classification of AML Once AML is diagnosed, it should be classified into the appropriate subtype based on WHO classification scheme Probably more familiar with FAB (next slide)
23 Type Name % of cases Mo acute myeloblastic leukemia, minimally differentiated 5 M1 acute myeloblastic leukemia, w/o maturation 15 M2 acute myeloblastic leukemia, with granulocytic maturation 25 M3 acute promyelocytic leukemia (APL) 10 M4 acute myelomonocytic leukemia 20 M4eo myelomonocytic together w BM eosinophilia 5 M5 acute monoblastic leukemia (M5a) or acutemonocytic leukemia (M5b) 10 M6 acute erythroid leukemias, including erythroleukemia (M6a) and very rare pure erythroid leukemia (M6b) 5 M7 acute megakaryoblastic leukemia 5
24 Poor Prognostic Factors Advanced age pts >55 y/o Poor performance status Eastern Cooperative Oncology Group (ECOG) scale used by oncologists Cytogenetic / Molecular genetic findings in tumor cells Hx of prior cytotoxic agents or radiation Hx of prior myelodysplasia or other hematologic disorders such as myeloproliferative neoplasms
25
26 Treatment Symptomatic Transfusions, allopurinol, hydroxyurea, etc Chemotherapy Cure rates of 30-40% Induction Chemo ( 7 and 3 ) 7d cytarabine + concomitant 3d anthracycline Goal is complete remission Consolidation Chemo follows (vs. allogenic HSCT) Goal is to eradicate residual disease If young + favorable risk disease > 3-4 courses of high dose cytarabine Adverse risk disease > allogenic HSCT after induction chemo
27 APL M3 subtype Presence of (15;17) gene translocation Creates the promyelocytic leukemia - retinoic acid receptor alpha fusion transcript Arrests leukemic cells at promyelocyte stage Landark APL0406 Trial (NEJM 2013, 3069 (2), Compared ATRA + ATO to ATRA + Anthracycline Chemo is specifically tailored to this gene translocation ATRA is added to induction & consolidation Binds a nuclear receptor to decrease proliferation & increase differentiation (maturation) of APL cells Cure in up to 80% Arsenic trioxide (ATO) can also induce differentiation ATRA + ATO demonstrated a 100% CR with 97% disease free survival at over 2 yrs of f/u with no deaths during induction This is a recently adopted category 1 treatment option for APL
28 Warning ATRA & Arsenic Trioxide may produce a differentiation syndrome Fever, dyspnea w or w/o pulmonary infiltrates, edema & hypotension Treatment: dexamethasone & temporarily stop the drugs
29 Board Question A 40yo W undergoes f/u evaluation after a 5 wk hospital stay. She was recently diagnosed with AML, with studies revealing a 5q- chromosomal deletion and 5 unrelated cytogenetic abnormalities. She was treated with induction chemo and is now experiencing full remission. The patient s brother is a complete HLA-matched donor. The physical examination, including vital signs, is normal. Lab studies, including CBC, are normal. Which of the following is the most appropriate treatment? 1. Allogenic HSCT 2. Autologous HSCT 3. Azacitidine 4. High-dose cytarabine She has high risk/adverse disease (5q-); thus, need induction and then allogenic HSCT (which has shown improved disease free survival) Studies using allogenic HSCT are not consistent - no definite proven benefit High Dose-C: only for favorable disease
30 ALL Malignancy of B or T lymphoblasts Cytochemical stains and Flow cytometry will differentiate T from B cell Often get lumped as lymphoma/ leukemia so here s a few tips: Lymphoma if a mass in mediastinum or elsewhere and < 25% blasts in BM If >25% blasts in BM (mass or no mass) -> it s leukemia
31 All presentation Similar symptoms to AML due to marrow failure fatigue, dyspnea, bleeding, infection/fever) BUT unlike AML, lymphadenopathy & organomegaly are common CNS involvement is common (HA, lethary, N/V, nuchal rigidity, CN palsy, or radiculopathy) TLS is common at time of diagnosis Poor prognosis: advanced age, adverse cytogenetics, B cell disease, and high WBC (>30,000): High risk: hypodiploidy & Philadelphia chromosome t(9;22)
32 Chemotherapy 30-40% cure rate for adults using standard chemo For young adults: Induction: anthracycline, vincristine, L-asparaginase, & corticosteroid If CR achieved > more intensive chemo with multiple agents for several months then 2-3 years of maintenance chemo Intrathecal chemo/radiation is also routinely given due to high risk for CNS disease If high risk disease, healthy, and donor available > allogeneic HSCT in first remission If Philadelphia chromosome + > BCR-ABL inhibitors are also given
33 Care of the adult survivor of childhood leukemia Fairly morbid cohort of pts And not uncommon over 300,000 survivors of childhood cancer as of 2010 ALL is most common childhood cancer Majority of long-term issues related to treatment of prior leukemia (some iteration of R-CHOP regimen) Important to collaborate with pt s oncologist OR survivor clinic to clarify prior treatments
34 Care of the adult survivor of childhood leukemia Cardiotoxicity (from anthracyclines) Echo rec d q3-5 yrs after establishing follow-up More cancer (!) Especially in pts that had received craniospinal radiation (brain, thyroid, parotid, sarcoma) Nearly 8x risk for AML compared to healthy population others can develop MDS Sustained bone demineralization
35
Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each
Introduction 1.1 Introduction: About 10,500 new cases of acute myelogenous leukemia are diagnosed each year in the United States (Hope et al., 2003). Acute myelogenous leukemia has several names, including
More informationAcute myeloid leukemia (AML)
Acute myeloid leukemia (AML) Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes abnormal myeloblasts (a type of white blood cell), red blood cells, or platelets. Adult
More informationAcute Myeloid Leukemia
Acute Myeloid Leukemia Introduction Leukemia is cancer of the white blood cells. The increased number of these cells leads to overcrowding of healthy blood cells. As a result, the healthy cells are not
More informationSWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I RESPONSE ASSESSMENT LEUKEMIA CHAPTER 11A REVISED: OCTOBER 2015
LEUKEMIA Response in Acute Myeloid Leukemia (AML) Response criteria in Acute Myeloid Leukemia for SWOG protocols is based on the review article Diagnosis and management of acute myeloid leukemia in adults:
More informationMatthew Ulrickson, MD Banner MD Anderson Cancer Center July 29, 2015
Matthew Ulrickson, MD Banner MD Anderson Cancer Center July 29, 2015 Discuss the clinical presentation and diagnosis of acute leukemia * Discuss the impact of molecular features on prognosis and management
More informationACUTE MYELOID LEUKEMIA (AML),
1 ACUTE MYELOID LEUKEMIA (AML), ALSO KNOWN AS ACUTE MYELOGENOUS LEUKEMIA WHAT IS CANCER? The body is made up of hundreds of millions of living cells. Normal body cells grow, divide, and die in an orderly
More informationAdult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2
Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2 Leukaemia: Description A group of malignant disorders affecting: White blood cells (lymphocytes or leucocytes) Bone
More informationAcute myeloid leukaemia (AML) in children
1 61.02 Acute myeloid leukaemia (AML) in children AML can affect children of any age, and girls and boys are equally affected. Leukaemia Acute myeloid leukaemia (AML) FAB classification of AML Causes of
More informationChildhood Cancer in the Primary Care Setting
Childhood Cancer in the Primary Care Setting Mohamed Radhi, M.D. Associate Professor, UMKC Pediatric Hematology/Oncology/BMT Children s Mercy Hospital I will discuss: Overview of childhood cancer Presentation
More informationEstimated New Cases of Leukemia, Lymphoma, Myeloma 2014
ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the
More informationimmunologic-- immunophenotypes are found by monoclonal antibodies - B-progenitor cells T-progenitor cells, mature B cells
Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Childhood ALL was the first form of cancer shown to be curable with chemotherapy and irradiation. Lymphoid leukemias
More informationAcute leukemias and myeloproliferative neoplasms
Acute leukemias and myeloproliferative neoplasms GERGELY SZOMBATH SEMMELWEIS UNIVERSITY OF MEDICINE IIIRD. DEPARTMENT OF INTERNAL MEDICINE Basics of acute leukemia Neoplastic disease Cell of origin is
More informationAPPROACH TO THE DIAGNOSIS AND TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) Hematology Rounds Thurs July 23, 2009 Carolyn Owen
APPROACH TO THE DIAGNOSIS AND TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) Hematology Rounds Thurs July 23, 2009 Carolyn Owen Outline Diagnosis Prognosis Treatment AML Elderly AML APL Future directions AML
More informationLEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials
LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational
More informationChildhood Leukemia Overview
Childhood Leukemia Overview What is childhood leukemia? Leukemia is a type of cancer that starts in early forms of blood cells. Cancer starts when cells grow out of control. Cells in nearly any part of
More informationCytogenetics for the Rest of Us: A Primer
Cytogenetics for the Rest of Us: A Primer James J. Stark, MD, FACP Medical Director Cancer Program Maryview Medical Center Diane Maia, M.D. Pathologist, Bon Secours Hampton Roads Case #1 78 y.o. lady seen
More informationCML. cure. A Patient s Guide. Molecular Biology Diagnosis Stem Cell Transplant Monitoring New Drugs Questions to Ask and More
A Patient s Guide to CML Molecular Biology Diagnosis Stem Cell Transplant Monitoring New Drugs Questions to Ask and More cure C a n c e r U p d at e s, R e s e a r c h & E d u c at i o n Based on science,
More informationMyelodysplasia Acute Myeloid Leukemia Chronic Myelogenous Leukemia Non Hodgkin Lymphoma Chronic Lymphocytic Leukemia Plasma Cell (Multiple) Myeloma
Myelodysplasia Acute Myeloid Leukemia Chronic Myelogenous Leukemia Non Hodgkin Lymphoma Chronic Lymphocytic Leukemia Plasma Cell (Multiple) Myeloma Hodgkin Lymphoma Overview Case Pathophysiology Diagnosis
More informationWhat is acute myeloblastic leukaemia?
Acute Myeloblastic Leukaemia What is acute myeloblastic leukaemia? Let us explain it to you. www.anticancerfund.org www.esmo.org ESMO/ACF Patient Guide Series based on the ESMO Clinical Practice Guidelines
More informationHematologic Malignancies
Hematologic Malignancies Elizabeth A. Griffiths, MD Leukemia Service, Department of Medicine Roswell Park Cancer Institute SUNY-UB School of Medicine Blood cancers are normal blood cells gone bad Jordan
More informationLeukemias and Lymphomas: A primer
Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes
More informationAggressive lymphomas. Michael Crump Princess Margaret Hospital
Aggressive lymphomas Michael Crump Princess Margaret Hospital What are the aggressive lymphomas? Diffuse large B cell Mediastinal large B cell Anaplastic large cell Burkitt lymphoma (transformed lymphoma:
More informationMy Sister s s Keeper. Science Background Talk
My Sister s s Keeper Science Background Talk Outline Acute promyelocytic leukemia (APL) APL Treatment Savior Siblings In vitro fertilization (IVF) Pre-implantation Genetic Diagnosis (PGD) Risks of donating
More informationACUTE MYELOGENOUS LEUKEMIA (AML)
Nicole Pearsall Clonal hematopoietic Disorders V Dr. Silberstein (#19) 9/23/03 The first 2 pages of Dr. Silberstein s notes are according to him the Gospel. This is what we are suppose to know for exam
More informationFastTest. You ve read the book... ... now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections
More informationPROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA PROGNOSIS IN ACUTE MYELOID LEUKEMIA
PROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA UNFAVORABLE Advanced age High leukocyte count at diagnosis Presence of myeloid antigens Late achievement of CR Chromosomal abnormalities: t(9:22)(q34:q11) t(4;11)(q21;q23)
More informationOncology Best Practice Documentation
Oncology Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: Solid Tumors Lymphomas Leukemias Myelodysplastic Syndrome Pathology Findings
More informationMalignant Lymphomas and Plasma Cell Myeloma
Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations
More informationWhat is a Stem Cell Transplantation?
What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am
More informationHodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla
Hodgkin Lymphoma Disease Specific Biology and Treatment Options John Kuruvilla My Disclaimer This is where I work Objectives Pathobiology what makes HL different Diagnosis Staging Treatment Philosophy
More informationSubtypes of AML follow branches of myeloid development, making the FAB classificaoon relaovely simple to understand.
1 2 3 4 The FAB assigns a cut off of 30% blasts to define AML and relies predominantly on morphology and cytochemical stains (MPO, Sudan Black, and NSE which will be discussed later). Subtypes of AML follow
More informationDisease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
More informationCorporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll
More informationAsymptomatic or smoldering myeloma with no symptoms and slow growing cancer cells
ESSENTIALS Multiple Myeloma Diagnosed with Multiple Myeloma? It s important to understand everything you can about your diagnosis, possible treatments, and places to go for support and care. Cancer is
More informationA 32 year old woman comes to your clinic with neck masses for the last several weeks. Masses are discrete, non matted, firm and rubbery on
A 32 year old woman comes to your clinic with neck masses for the last several weeks. Masses are discrete, non matted, firm and rubbery on examination. She also has fever, weight loss, and sweats. What
More informationAcute Myelogenous Leukemia: A Guide for Patients and Caregivers
Acute Myelogenous Leukemia: A Guide for Patients and Caregivers LE UK E M I A Printing of this publication made possible by an education grant from LYMPHOMA M Y E L OM A Introduction Table of Contents
More informationAr Mino changes including adjustment of therapy algorithms
cute Myeloid Leukemia Updated April 2008 by Dr. Richard Wells* Updates: Ar Mino changes including adjustment of therapy algorithms Introduction Acute myeloid leukemia is a relatively uncommon cancer with
More informationMyelodysplasia. Dr John Barry
Myelodysplasia Dr John Barry Myelodysplasia Group of heterogenouus bone marrow disorders that are due to a defect in stem cells. Increasing bone marrow failure leading to quan>ta>ve and qualita>ve abnormali>es
More information1 Acute Myeloid Leukaemia
1 Acute Myeloid Leukaemia 1.17 Idarubicin Pre-treatment Evaluation Morphology of blood and bone marrow aspirate. Trial patients: send 6 unstained slides to Leeds General Infirmary. Trephine biopsy and
More informationAnswering your questions on Chronic Myeloid Leukaemia (CML)
Answering your questions on Chronic Myeloid Leukaemia (CML) Your guide to understanding CML and Glivec (imatinib) treatment The information in this booklet is designed to help you understand chronic myeloid
More informationLeukemia Acute Myeloid (Myelogenous)
Leukemia Acute Myeloid (Myelogenous) What is acute myeloid leukemia? Cancer starts when cells in a part of the body begins to grow out of control and can spread to other areas of the body. There are many
More informationMALIGNANT LYMPHOMAS. Dr. Olga Vujovic (Updated August 2010)
MALIGNANT LYMPHOMAS Dr. Olga Vujovic (Updated August 2010) Malignant lymphomas consist of Hodgkin and non-hodgkin lymphomas. The current management of these diseases involves a multi-disciplinary approach.
More informationNational Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s National Cancer Institute
More informationOncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control
Oncology Objectives Describe the etiology and pathophysiological mechanisms of cancer Discuss medical and family history findings relevant to cancer Identify general signs and symptoms associated with
More informationAcute Myelogenous Leukemia Pre-HSCT Data
Instructions for Acute Myelogenous Leukemia Pre-HSCT Data (Form 2010) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the AML Pre-HSCT Data Form. E-mail
More informationCanine Lymphoma Frequently Asked Questions by Pet Owners
Canine Lymphoma Frequently Asked Questions by Pet Owners What is lymphoma? The term lymphoma describes a diverse group of cancers in dogs that are derived from white blood cells called lymphocytes. Lymphocytes
More informationUpdate in Hematology Oncology Targeted Therapies. Mark Holguin
Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning
More informationPERIPHERAL STEM CELL TRANSPLANT INTRODUCTION
PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION This booklet was designed to help you and the important people in your life understand the treatment of high dose chemotherapy with stem cell support: a procedure
More informationBrain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.
Brain Cancer Introduction Brain tumors are not rare. Thousands of people are diagnosed every year with tumors of the brain and the rest of the nervous system. The diagnosis and treatment of brain tumors
More informationFor further advice contact the clinical information team on 020 7269 9060.
Revised June 2011 The diagnosis of a blood cancer can be a devastating event for patients, families and friends. It is therefore vital for everyone to have access to reputable and understandable information
More informationPROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA
2012 1 31,, PROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA Version 1.0 2012 DIVISION OF HAEMATOLOGY / ONCOLOGY DEPARTMENT OF MEDICINE KAOHSING VETERAN GENERAL HOSPTIAL General Guide Diagnosis 1.Adequate
More informationChronic Lymphocytic Leukemia. Case Study. AAIM Triennial October 2012 Susan Sokoloski, M.D.
Chronic Lymphocytic Leukemia AAIM Triennial October 2012 Susan Sokoloski, M.D. Case Study 57 year old male, trial application for $1,000,000 Universal Life coverage Cover letter from sales agent indicates
More informationCHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.
Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs
More informationHematopathology VII Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, And Hairy Cell Leukemia
John L. Kennedy, M.D. UIC College of Medicine Associate Professor of Clinical Pathology M2 Pathology Course Lead Pathologist, VA Chicago Health Care System Lecture #43 Phone: (312) 569-6690 Thursday, November
More informationPathology No: SHS-CASE No. Date of Procedure: Client Name Address
TEL #: (650) 725-5604 FAX #: (650) 725-7409 Med. Rec. No.: Date of Procedure: Sex: A ge: Date Received: Date of Birth: Account No.: Physician(s): Client Name Address SPECIMEN SUBMITTED: LEFT PIC BONE MARROW,
More informationBlood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide
Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood
More informationLeuJaiemuititckUdkovd
LeuJaiemuititckUdkovd Leukaemia is one of the more common childhood cancers. MARIANA KRUGER, MB ChB, MMed Paed, MPhil (Applied Ethics), PhD Professor and Executive Head, Department of Paediatrics and Child
More informationGRANIX (tbo-filgrastim)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil
More informationA Science Writer s Guide to Multiple Myeloma
A Science Writer s Guide to Multiple Myeloma 1 A Science Writer s Guide to Multiple Myeloma A Science Writer s Guide to Multiple Myeloma PREFACE Blood cancers and related disorders a serious health risk
More informationThe CML Guide Information for Patients and Caregivers
The CML Guide Information for Patients and Caregivers LEUKEMIA LYMPHOMA CHRONIC MYELOGENOUS LEUKEMIA MYELOMA Printing of this publication made possible by a grant from A Message from John Walter President
More informationLeukemia. Leukemia vs lymphoma The major types of leukemia are based on whether the disease is: Acute or chronic Lymphocytic or myeloid
Leukemia Leukemia vs lymphoma The major types of leukemia are based on whether the disease is: Acute or chronic Lymphocytic or myeloid Acute vs chronic leukemia rapid increase in immature blood cells.
More informationStem Cell Transplantation
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
More informationLYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons
LYMPHOMA BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons Normal development of lymphocytes Lymphocyte proliferation and differentiation:
More informationINFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002
INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 COVERAGE: SPECIAL COMMENT ON POLICY REVIEW: Due to the complexity of the Peripheral and Bone Marrow Stem Cell Transplantation
More informationI was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several
Track 3: Goals of therapy I was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several factors she ll use to decide what s best for me. Let s talk about making treatment
More informationCorso Integrato di Clinica Medica ONCOLOGIA MEDICA AA 2010-2011 LUNG CANCER. VIII. THERAPY. V. SMALL CELL LUNG CANCER Prof.
Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA 2010-2011 LUNG CANCER. VIII. THERAPY. V. SMALL CELL LUNG CANCER Prof. Alberto Riccardi SMALL CELL LUNG CARCINOMA Summary of treatment approach * limited
More informationCASE 2. Seven week old female infant presents with hepatosplenomegaly l and WBC 31.0k/mm 3, Hgb 9.2 g/dl, Plt 110k/mm 3 with 60% blasts
CASE 2 Seven week old female infant presents with hepatosplenomegaly l and WBC 31.0k/mm 3, Hgb 9.2 g/dl, Plt 110k/mm 3 with 60% blasts A bone marrow biopsy and aspirate were performed (photos provided).
More informationThe AML Guide. Information for Patients and Caregivers. Acute Myeloid Leukemia. Emily, AML survivor
The AML Guide Information for Patients and Caregivers Acute Myeloid Leukemia Emily, AML survivor Revised 2012 A Message from Louis J. DeGennaro, PhD President and CEO of The Leukemia & Lymphoma Society
More informationDisclosures. I have no disclosures.
Not Your Own Marrow Jenni Krajewski, MD Clinical Assistant Professor, Rutgers New Jersey Medical School Attending Physician, Pediatric Blood and Marrow Transplantation The Institute for Pediatric Cancer
More informationMultiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.
Multiple Myeloma Introduction Multiple myeloma is a type of cancer that affects white blood cells. Each year, thousands of people find out that they have multiple myeloma. This reference summary will help
More informationLeukemia: Acute Myeloid (Myelogenous) Overview
Leukemia: Acute Myeloid (Myelogenous) Overview This overview is based on the more detailed information in our document, Leukemia- Acute Myeloid. You can get this document and other information by calling
More informationChildhood Leukemia. Normal bone marrow, blood, and lymphoid tissue
Childhood Leukemia What is childhood leukemia? Cancer starts when cells start to grow out of control. Cells in nearly any part of the body can become cancer. To learn more about how cancers start and spread,
More informationchronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart
Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart
More informationGuideline for the Management of Acute Lymphoblastic Leukaemia (ALL) in Adults
Guideline for the Management of Acute Lymphoblastic Leukaemia (ALL) in Adults Version History Version Date Summary of Change/Process 1.0 The UKALL trial protocol was approved as version 1. 1.1 22.07.10
More informationNarrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood
[Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,
More informationProject Lead: Stephen Forman, M.D. PI: Elizabeth Budde, M.D., Ph.D
Phase I study using T cells expressing a CD123-specific chimeric antigen receptor and truncated EGFR for patients with relapsed or refractory acute myeloid leukemia Project Lead: Stephen Forman, M.D. PI:
More informationMultiple Myeloma Understanding your diagnosis
Multiple Myeloma Understanding your diagnosis Multiple Myeloma Understanding your diagnosis When you first hear that you have cancer you may feel alone and afraid. You may be overwhelmed by the large amount
More information亞 東 紀 念 醫 院 Follicular Lymphoma 臨 床 指 引
前 言 : 惡 性 淋 巴 瘤 ( 或 簡 稱 淋 巴 癌 ) 乃 由 體 內 淋 巴 系 統 包 括 淋 巴 細 胞 淋 巴 管 淋 巴 腺 及 一 些 淋 巴 器 官 或 組 織 如 脾 臟 胸 腺 及 扁 桃 腺 等 所 長 出 的 惡 性 腫 瘤 依 腫 瘤 病 理 組 織 型 態 的 不 同 可 分 為 何 杰 金 氏 淋 巴 瘤 (Hodgkin s disease) 與 非 何 杰 金
More informationThymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.
Thymus Cancer Introduction Thymus cancer is a rare cancer. It starts in the small organ that lies in the upper chest under the breastbone. The thymus makes white blood cells that protect the body against
More informationLauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?
Hello, I m Lauren Berger and I m the Senior Director of Patient Services Programs at The Leukemia & Lymphoma Society. I m pleased to welcome Dr. Rebecca Elstrom. Dr. Elstrom is an Assistant Professor in
More informationMULTIPLE MYELOMA Review & Update for Primary Care. Dr. Joseph Mignone 21st Century Oncology
MULTIPLE MYELOMA Review & Update for Primary Care Dr. Joseph Mignone 21st Century Oncology OVERVIEW Identify the diagnostic criteria for multiple myeloma Compare first & second line therapies, using data
More informationGuidelines for the Management of Acute Myelogenous Leukemia in Adults
Guidelines for the Management of Acute Myelogenous Leukemia in Adults Guidelines for the Management of Acute Myelogenous Leukemia in Adults - Guidelines for the Management of Acute Myelogenous Leukemia
More informationLYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis
LYMPHOMA IN DOGS Lymphoma is a relatively common cancer in dogs. It is a cancer of lymphocytes (a type of white blood cell) and lymphoid tissues. Lymphoid tissue is normally present in many places in the
More informationCollect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.
Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,
More informationStem Cell Transplantation for Acute Lymphoblastic Leukemia
Stem Cell Transplantation for Acute Lymphoblastic Leukemia Mona Shafey MD, FRCPC Bone Marrow Transplant Fellow Alberta Blood and Marrow Transplant Program 1 of 14 Stem Cell Transplantation for Acute Lymphoblastic
More informationHospital Outpatient Coding and Billing Information Sheet for Neulasta and NEUPOGEN
Hospital Outpatient Coding and Billing Information Sheet for Neulasta and Neulasta Delivery Kit Neulasta Prefilled Syringe For assistance contact 1-844-MYNEULASTA (1-844-696-3852) or visit www.amgenassistonline.com
More informationBone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Bone Marrow Transplantation
More informationOther treatments for chronic myeloid leukaemia
Other treatments for chronic myeloid leukaemia This information is an extract from the booklet Understanding chronic myeloid leukaemia. You may find the full booklet helpful. We can send you a copy free
More informationEmerging New Prognostic Scoring Systems in Myelodysplastic Syndromes 2012
Emerging New Prognostic Scoring Systems in Myelodysplastic Syndromes 2012 Arjan A. van de Loosdrecht, MD, PhD Department of Hematology VU University Medical Center VU-Institute of Cancer and Immunology
More informationThings You Don t Want to Miss in Multiple Myeloma
Things You Don t Want to Miss in Multiple Myeloma Sreenivasa Chandana, MD, PhD Attending Hematologist and Medical Oncologist West Michigan Cancer Center Assistant Professor, Western Michigan University
More informationWhat You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide
For Patients What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide Patients: Your doctor or nurse will go over this patient guide with you. It is important to ask any questions
More information3% Chronic leukemia Chronic myelocytic leukemia Juvenile myelomonocytic leukemia Risk Factors for Childhood Acute Leukemia
CHILDHOOD LEUKEMIA 97% Acute leukemia 75% Acute lymphoblastic leukemia 20% Acute myeloblastic leukemia Acute mixed lineage leukemia Acute undifferentiated leukemia 3% Chronic leukemia Chronic myelocytic
More informationAn overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham
An overview of CLL care and treatment Dr Dean Smith Haematology Consultant City Hospital Nottingham What is CLL? CLL (Chronic Lymphocytic Leukaemia) is a type of cancer in which the bone marrow makes too
More informationLung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.
Lung Cancer Introduction Lung cancer is the number one cancer killer of men and women. Over 165,000 people die of lung cancer every year in the United States. Most cases of lung cancer are related to cigarette
More informationAcute Myelogenous Leukemia
Acute Myelogenous Leukemia LEUKEMIA LYMPHOMA MYELOMA Printing of this publication made possible by an education grant from: Table of Contents Introduction 2 Normal Blood and Marrow 3 Leukemia 5 Acute Myelogenous
More informationTreating Acute Promyelocytic Leukemia (AML-M3)
Treating Acute Promyelocytic Leukemia (AML-M3) Recorded on: February 7, 2014 Lloyd E. Damon, M.D. Director of Hematology and Blood and Marrow Transplantation UCSF Medical Center Nancy White Gamble APL
More informationMEDICAL COVERAGE POLICY
Important note Even though this policy may indicate that a particular service or supply is considered covered, this conclusion is not necessarily based upon the terms of your particular benefit plan. Each
More informationSummary of the risk management plan (RMP) for Accofil (filgrastim)
EMA/475472/2014 Summary of the risk management plan (RMP) for Accofil (filgrastim) This is a summary of the risk management plan (RMP) for Accofil, which details the measures to be taken in order to ensure
More informationHydroxyurea Treatment for Sickle Cell Disease
Hydroxyurea Treatment for Sickle Cell Disease Before hydroxyurea After hydroxyurea Hydroxyurea Treatment for Sickle Cell Disease 1 This document is not intended to take the place of the care and attention
More informationTreating Minimal Residual Disease in Acute Leukemias: How low should you go?
Treating Minimal Residual Disease in Acute Leukemias: How low should you go? Ramsie Lujan, Pharm.D. PGY1 Pharmacy Practice Resident Methodist Hospital, San Antonio, Texas Pharmacotherapy Education and
More information